Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | DAO | P14920 | 1/20 | 0.34 |
| ▸ | GSTP1 | P09211 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MC4R | P32245 | 1/20 | 0.31 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11211634 | 0.88 | GSTP1 (0.45) | DAOGSTP1MAPT | |
| SCHEMBL1238353 | 0.82 | HCAR2 (0.32) | GSTP1CYP1A2 | |
| SCHEMBL1078427 | 0.79 | DAO (0.38) | DAOGSTP1CYP1A2SORT1 | |
| SCHEMBL6901471 | 0.79 | GSTP1 (0.33) | GSTP1CYP1A2ALDH1A1 | |
| SCHEMBL4285502 | 0.78 | ALDH1A1 (0.35) | GSTP1CYP1A2ALDH1A1 | |
| SCHEMBL6898539 | 0.76 | FNTA (0.39) | DAOGSTP1 | |
| SCHEMBL6902175 | 0.76 | GSTP1 (0.31) | GSTP1 | |
| SCHEMBL11733124 | 0.75 | ALDH1A1 (0.33) | GSTP1ALDH1A1 | |
| SCHEMBL6895221 | 0.75 | FNTA (0.35) | DAOGSTP1 | |
| SCHEMBL1340149 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7649107-B2 | Process for the preparation of cyclopentanone derivatives | FIRMENICH SA (CH) | 2010-01-19 | — | — | US | disclosed |
| US-20080214859-A1 | Process for the Preparation of Cyclopentanone Derivatives | FIRMENICH SA (CH) | 2008-09-04 | — | — | US | disclosed |
| US-6833481-B2 | Catalytic dehydrative isomerization | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2004-12-21 | — | — | US | disclosed |
| US-20030109755-A1 | Process for producing 2-alkyl-2cyclopentenones | TAKASAGO INTERNATIONAL CORPORATION | 2003-06-12 | — | — | US | disclosed |
| EP-1316541-A1 | Process for producing 2-alkyl-2-cyclopentenones | Takasago International Corporation (JP) | 2003-06-04 | — | — | EP | disclosed |
| CN-1421429-A | Process for producing 2-alkyl-2-cyclopentenone | TAKASAGO PERFUMERY CO LTD (JP) | 2003-06-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080214859-A1 | Process for the Preparation of Cyclopentanone Derivatives | DHPS, CBR3, CBR1 | PTPN1 4077/4885DAO 1261/4885GSTP1 1580/4885 |
| US-20030109755-A1 | Process for producing 2-alkyl-2cyclopentenones | HSD3B2, DHPS, HSD3B1 | PTPN1 4588/4885DAO 2558/4885GSTP1 2717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.